The U.S. Food and Drug Administration today expanded the approved use of regorafinib to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib. This is the first...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2pFIcja
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
When you make pizza this good you are allowed to brag about it. Come try a square of the best pizza in Erie. Ohhh yeah, we have ice cream no...
-
British Journal of Oral and Maxillofacial Surgery... Stem Cells and DevelopmentMesenchymal Stem/Stroma... [ASAP] Self-Assembly of Giant Mo...
-
Abstract ᅟ http://ift.tt/2pGNeby
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2o6Gupp via IFTTT
-
The efficacy and optimization of poststroke physical therapy paradigms is challenged in part by a lack of objective tools available to resea...
-
Related Articles Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities. Th...
-
Related Articles Dumbbell-shaped Jugular Foramen Tumors Extending to the Neck: Surgical Considerations Based on Imaging Findings. Wor...
-
Publication date: Available online 18 January 2017 Source: Free Radical Biology and Medicine Author(s): Philip Wenzel, Sabine Kossmann, Th...
-
Publication date: October 2017 Source: Microbiological Research, Volume 203 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου